Phillips-Medisize LLC (Phillips-Medisize), a subsidiary of Molex LLC, is a provider of innovation, development and manufacturing solutions to the drug delivery, diagnostics, med tech, defense, automotive and consumer markets. The company offers design and development, manufacturing development, commercial manufacturing, clinical manufacturing, and post-launch services. The company carries out the design, development, and manufacturing of multi-component medical devices such as components, sub-assemblies and fully finished devices ready-for-use. It produced hundreds of millions of units in various types, including stent delivery systems, percutaneous introducers, implantable device delivery systems, hemostatic valve systems, electrophysiology 3D mapping systems, contrast media delivery device systems, single and multiple use surgical devices, minimally invasive surgical devices, custom fiber optics and fiber optic tubing solutions, and custom cable sub-assembly solutions. In the diagnostic market, the company design, develop, and production of diagnostic and reusable consumables and point-of-care diagnostic products. It produces hundreds of millions of units every year in the various types, including finished, labeled diagnostics consumables, kits and cartridges, glucose monitors and meters, diagnostics for women’s health, rapid point of care diagnostic tests, diagnostic sample kits for home use and brachytherapy disposables. Its diagnostic products are designed, developed, and produced as per internationally recognized quality management standards. Phillips-Medisize’s clean room production facilities are FDA-registered Class 8 and Class 7. Phillips-Medisize also designs and manufactures custom plastic and metal injection molded components for the consumer market. It has expertise in plastic and magnesium thin wall molding; metal injection molding; magnesium injection molding; multi-shot molding; LCD lenses; decorating options includes painting, laser etching, electroplating, pad printing, in-mold decorating, hot stamping, printed appliques and others; and consumer product manufacturing.The company also offers actuators and radio assemblies to sensors, switches and instrument cluster components to the automotive industry. The company also carries out secondary operations such as painting, EMI/RFI shielding, laser etching, plating and a blend of proprietary and non-proprietary coatings to protect electronic transmissions and prevent harmful corrosion of metals in the defense industry.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Phillips-Medisize focuses on innovating capabilities in the design, development, and manufacturing of drug-delivery products. The company emphasizes product innovation to achieve rapid commercialization. Phillips-Medisize develops therapy-specific features, functions, and designs for each new application, ensuring individual patient needs and the unique characteristics of each drug. Phillips-Medisize integrates product development and commercial manufacturing to reduce risk and accelerate time to market, combining user-centric design with an emphasis on manufacturing.The R&D units of the company include seven innovation centers and 23 production facilities across the US, Europe, and Asia. These units are responsible for managing the company's R&D activities, ensuring collaboration across continents, and delivering services where customers are located. The units focus on new product introduction, tool-building, and maintaining global standards for injection molding, automation, and validation.The company operates in seven R&D centers which has been involved in the development of various products, including autoinjectors, ocular drug delivery systems, in vitro diagnostic devices, pen injectors, inhalation devices, and electro-mechanical drug delivery devices. The company focuses on designing and innovating physical, digital, and service products, developing them through an agile, controlled process, and integrating product and manufacturing development to deliver safe and effective products.